Genetic support for FDA-approvals over the past decade

From ELRIG (UK) Ltd.Reviewed by Megan Craig, M.Sc.

Since genetic evidence can identify the underlying causes of diseases, it has frequently been used as a surrogate for drug development success. An extensive retrospective analysis of the genetic basis for drug approvals during the previous 10 years was carried out by acCELLerate.

Association score > 0.

Association score > 0

FDA-approved drugs

Genetics for acceleration?

Genetic support for FDA-approvals over the past decade

FDA-accelerated approvals were more likely to be based on genetic evidence [OR = 9.5 (2.3 - 40), p < 0.002). This correlation could indicate a focus on genetics for critical reasons, or a better knowledge of the causal relationship for faster therapies.

Last Updated: May 16, 2024

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

APA
ELRIG (UK) Ltd.. (2024, May 16). Genetic support for FDA-approvals over the past decade. News-Medical. Retrieved on June 01, 2024 from https://www.news-medical.net/health/Genetic-support-for-FDA-approvals-over-the-past-decade.aspx.
MLA
ELRIG (UK) Ltd.. "Genetic support for FDA-approvals over the past decade". News-Medical. 01 June 2024. <https://www.news-medical.net/health/Genetic-support-for-FDA-approvals-over-the-past-decade.aspx>.
Chicago
ELRIG (UK) Ltd.. "Genetic support for FDA-approvals over the past decade". News-Medical. https://www.news-medical.net/health/Genetic-support-for-FDA-approvals-over-the-past-decade.aspx. (accessed June 01, 2024).
Harvard
ELRIG (UK) Ltd.. 2024. Genetic support for FDA-approvals over the past decade. News-Medical, viewed 01 June 2024, https://www.news-medical.net/health/Genetic-support-for-FDA-approvals-over-the-past-decade.aspx.